Apollo Endosurgery, Inc.: 10-Q filed 2016-11-10
What Apollo Endosurgery, Inc. reported in its quarterly report filed 2016-11-10 (fiscal Q3 2016): 25 published measures, 62 facts as tagged in accession 0001558370-16-009945.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2016-11-10
- Fiscal period
- fiscal Q3 2016
- Accession
- 0001558370-16-009945 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Apollo Endosurgery, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 4,047,960 | USD | |
| At 2015-12-31 | 11,612,445 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 1,357,864 | USD | |
| At 2015-12-31 | 1,080,454 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 2,690,096 | USD | |
| At 2015-12-31 | 10,531,991 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 3,324,279 | USD | |
| At 2015-12-31 | 8,889,616 | USD | |
| At 2015-09-30 | 11,553,615 | USD | |
| At 2014-12-31 | 17,282,325 | USD |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 21,117 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 23,807 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 42,658 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 61,254 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 1,592,776 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | -84,352,948 | USD | |
| At 2015-12-31 | -76,043,515 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 149,271 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 469,116 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 702,935 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -3,702,697 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -8,309,446 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -2,226,820 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -8,519,842 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 4,047,960 | USD | |
| At 2015-12-31 | 9,253,885 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 1,357,864 | USD | |
| At 2015-12-31 | 1,080,454 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 894,636 | USD | |
| At 2015-12-31 | 294,010 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-12-31 | 2,132,129 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 24,909 | USD | |
| At 2015-12-31 | 6,988 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 3,726,504 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 8,352,104 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 2,288,074 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 10,112,618 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 538,081 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 2,465,611 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 1,430,061 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 7,102,186 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 2,376,052 | shares | |
| At 2015-12-31 | 2,369,449 | shares |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 262,915 | USD | |
| At 2015-12-31 | 204,237 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 698,772 | USD | |
| At 2015-12-31 | 357,281 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -3,702,684 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -8,309,433 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -2,226,820 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -7,669,802 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 1,522,020 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 3,602,426 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 858,013 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 3,010,432 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 135,123 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 262,303 | USD | 273 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 13 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 13 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 40 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 17,921 | USD | 274 |
| 2015-01-01 to 2015-09-30 | -671,187 | USD | 273 |
Inspect the source
- Entity
- Apollo Endosurgery, Inc. / CIK 0001251769
- Captured
- SEC response SHA-256
308ca5de51c5ff3a6ebe7ea06081848be77e7c3a8b2c9b2bce1d856f60a70fce
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001251769.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))